Brought to you by:
Brex—The intelligent finance platform: cards, expenses, travel, bill pay, banking. Built for scale. Trusted by OpenAI, Anthropic, Vercel, Granola, Deepgram, & Sourcery.. teams that move fast AF. visit → brex.com/sourcery
Neko Health Opens in NYC
FULL TOUR » Watch on X
This week I went in for a 60min visit at Neko, I walk through from start to finish the full experience, & of course give a glimpse of where those famous yellow robe shots happen..
The FOMO is real.
Demand in New York was already significant before the doors opened: more than 30,000+ New Yorkers joined the waitlist ahead of launch.
Founded by Hjalmar Nilsonne & Spotify’s Daniel Ek, Neko launched its first clinic in Stockholm in 2023. It has since expanded across Sweden and the UK and completed more than 100,000 scans.
The Neko Health Scan costs $499 & takes around 60 minutes (~30min tests/scans, ~30min doctor review). The experience is non-invasive and radiation-free, combining proprietary sensors, imaging, blood analysis and clinical review to capture millions of data points across the body.
It measures cardiovascular health, circulation, skin, blood, metabolic health and body composition. Neko’s technology can detect skin changes as small as 0.2 millimeters, while its cardiovascular measurements include ECG, blood pressure, oxygen saturation, arterial stiffness, heart and breathing rate.
The company recently added body composition analysis and wearable data integration, giving clinicians additional information on what is happening between annual visits.
But one of the biggest differences is speed.
Rather than completing tests and waiting days or weeks for results from different providers, Neko designed the experience around getting the data back during the same visit. Results are processed on-site within minutes and then reviewed directly with a clinician.
Hjalmar Nilsonne, Neko Health Co-Founder & CEO:
“What if a single visit could give you a more complete picture of your health, where it’s heading, and a clear plan from a medical professional to change what happens next?”
Neko also builds its hardware, software and clinical protocols in-house. That vertical integration allows the company to control the entire experience — from the sensors collecting the data to how clinicians interpret and present the results.
Nilsonne describes that integration as fundamental to the model:
“This vertical integration is not incidental; it is the foundation that allows Neko Health to control the experience from start to finish, to move faster and to improve continuously.”
There are early signs that members are actually coming back. 75% of members book and prepay for their next annual scan at the end of their first appointment, 80% rebook after their second scan for a third scan
Neko has also started publishing data on what happens to members over time. Among returning members who had previously been identified with severe or life-threatening conditions, the company says three in four were either in good health or had the condition under control at follow-up. Across the broader returning population, five of seven key biomarkers showed statistically significant improvement between the first and second scans.
That data comes from Neko’s own member population and should be viewed as company-reported observational results, rather than evidence from a randomized clinical trial.
The U.S. launch follows a $700 million Series C in July led by Lightspeed and co-led by O.G. Venture Partners. More than 350,000 people globally have now joined the waitlist or registered for a scan.
“The clearest proof is in our members: the vast majority of our members return after their first scan, and when they do, their health markers move in the right direction.” Nilsonne
New York is only the first step in the U.S. rollout. Neko plans additional NYC locations, followed by Miami, Washington, D.C. and San Francisco.
For Ek and Nilsonne, the larger bet is that healthcare can move from primarily reacting to disease toward measuring more, earlier.. and giving people information they can act on before something feels wrong.
Neko has already become a cultural movement.
Brought to you by:
Zone—develops next-generation data center campuses, partnering with AI companies, site developers and technology leaders to bring compute online faster and at scale. Visit: zonefrontier.com
Turing—Turing partners with frontier AI labs to improve model capabilities in coding, reasoning, tool use, & multimodality, as well as with Fortune 500 enterprises to build & deploy end-to-end agentic AI systems in mission-critical workflows Visit: turing.com/sourcery
VCX—VCX is the public ticker for private tech, allowing investors of all sizes to invest in venture capital. View The Portfolio at GetVCX.com
Deel—Deel is the global people platform that helps startups hire, manage, pay, and equip anyone, anywhere. Trusted by more than 35,000 fast-growing companies, Deel is the people platform that just works, so teams can scale without the chaos. Visit: deel.com/sourcery
Public-–Investing platform Public just launched Generated Assets, which lets you turn any idea into an investable index with AI. With Generated Assets, you can build, backtest, refine, and invest in any thesis with AI. Gone are the days of one-size-fits-all ETFs. Try it today: public.com/sourcery
The material presented on Molly O’Shea’s website are my opinions only and are provided for informational purposes and should not be construed as investment advice. It is not a recommendation of, or an offer to sell or solicitation of an offer to buy, any particular security, strategy, or investment product. Any analysis or discussion of investments, sectors or the market generally are based on current information, including from public sources, that I consider reliable, but I do not represent that any research or the information provided is accurate or complete, and it should not be relied on as such. My views and opinions expressed in any website content are current at the time of publication and are subject to change. Past performance is not indicative of future results.
Paid Endorsement. Brokerage services by Open to the Public Investing Inc, member FINRA & SIPC. Advisory services by Public Advisors LLC, SEC-registered adviser. Crypto trading provided by Zero Hash LLC, licensed by the NYSDFS. Generated Assets is an interactive analysis tool by Public Advisors. Output is for informational purposes only and is not an investment recommendation or advice. See disclosures at public.com/disclosures/ga. Matched funds must remain in your account for at least 5 years. Match rate and other terms are subject to change at any time.
The healthcare market is starting to fragment with services like these. Maybe it will incentivize the broader market to modernize too and level it out over the long term.